InhibrxInc Asset Turnover Over Time
| INBX Stock | USD 34.74 0.24 0.69% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out InhibrxInc Performance and InhibrxInc Correlation. InhibrxInc |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Asset Turnover Analysis
Compare InhibrxInc and related stocks such as Crinetics Pharmaceuticals, Merus BV, and Lyell Immunopharma Asset Turnover Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRNX | 0.0467 | 0.0467 | 0.0467 | 0.0467 | 0.0467 | 0.0467 | 0.0467 | 0.1311 | 0.0142 | 0.0092 | 4.0E-4 | 0.0031 | 0.0135 | 0.0063 | 0.006 |
| MRUS | 0.0152 | 0.0152 | 0.0152 | 0.0152 | 0.2195 | 0.037 | 0.0376 | 0.063 | 0.1439 | 0.1182 | 0.1295 | 0.1075 | 0.1104 | 0.0959 | 0.0784 |
| LYEL | 0.0012 | 0.0012 | 0.0012 | 0.0012 | 0.0012 | 0.0012 | 0.0012 | 0.0012 | 0.0012 | 0.0012 | 0.0085 | 0.0094 | 0.0903 | 2.0E-4 | 2.0E-4 |
| KRON | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0295 | 0.0265 | 0.0236 |
| OPT | 0.0438 | 0.0043 | 0.0043 | 0.0043 | 0.0043 | 0.0043 | 0.0043 | 0.0043 | 0.0043 | 0.0012 | 5.0E-4 | 0.0015 | 0.0011 | 0.0013 | 0.0012 |
| MLYS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ELYM | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ANEB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| MACK | 0.0261 | 0.4011 | 0.3284 | 0.2483 | 0.6477 | 0.38 | 1.7706 | 1.7706 | 1.7706 | 1.7706 | 1.7706 | 1.7706 | 1.7706 | 1.59 | 1.67 |
| CELC | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ELVN | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| GLUE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| DSGN | 0.0093 | 0.0093 | 0.0093 | 0.0093 | 0.0093 | 0.0093 | 0.0093 | 0.0093 | 0.0093 | 0.0093 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| HOWL | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1023 | 0.1141 | 0.088 |
| IKNA | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.0546 | 0.125 | 0.0907 | 0.0477 | 0.0453 |
| STOK | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0484 | 0.0385 | 0.0477 |
| PTGX | 0.1225 | 0.1225 | 0.1225 | 0.1225 | 0.1225 | 0.1225 | 0.1225 | 0.1225 | 0.2217 | 0.0015 | 0.0882 | 0.0787 | 0.1072 | 0.1676 | 0.12 |
| LRMR | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| VRDN | 1.5845 | 1.5845 | 1.5845 | 1.1753 | 0.5341 | 0.1967 | 0.7835 | 0.0763 | 0.1268 | 0.1474 | 0.008 | 0.0145 | 0.0041 | 6.0E-4 | 6.0E-4 |
InhibrxInc and related stocks such as Crinetics Pharmaceuticals, Merus BV, and Lyell Immunopharma Asset Turnover description
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.My Equities
My Current Equities and Potential Positions
| InhibrxInc | INBX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 34.74
Check out InhibrxInc Performance and InhibrxInc Correlation. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
InhibrxInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.